{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:05:41Z","timestamp":1769087141870,"version":"3.49.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.mcna.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T16:19:57Z","timestamp":1680106797000},"page":"465-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic Manifestations of Systemic Diseases"],"prefix":"10.1016","volume":"107","author":[{"given":"Humberto C.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2023.01.008_bib1","series-title":"Global tuberculosis report 2020","year":"2020"},{"key":"10.1016\/j.mcna.2023.01.008_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","article-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006","volume":"49","author":"Peto","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","article-title":"Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection","volume":"148","author":"Jones","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.gtc.2021.02.004","article-title":"Gastrointestinal and abdominal tuberculosis","volume":"50","author":"Eraksoy","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.mcna.2023.01.008_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12879-015-0944-6","article-title":"A\u00a0systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection","volume":"15","author":"Hickey","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib6","series-title":"Schiff's diseases of the liver","first-page":"218","article-title":"Hepatic manifestations of systemic disease","author":"Gordon","year":"2017"},{"key":"10.1016\/j.mcna.2023.01.008_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7869\/tg.2012.25","article-title":"Tuberculosis and liver disease: management issues","volume":"33","author":"Sonika","year":"2012","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.18683\/germs.2021.1266","article-title":"Hepatic tuberculosis: myriad of hues","volume":"11","author":"Choudhury","year":"2021","journal-title":"Germs"},{"key":"10.1016\/j.mcna.2023.01.008_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mcna.2023.01.008_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1440-1746.1998.tb00743.x","article-title":"Hepatobiliary tuberculosis","volume":"13","author":"Alvarez","year":"1998","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01710049","article-title":"Hepatic tuberculosis: comparison of miliary and local form","volume":"23","author":"Chien","year":"1995","journal-title":"Infection"},{"key":"10.1016\/j.mcna.2023.01.008_bib12","first-page":"759341","article-title":"Miliary tuberculosis induced acute liver failure","volume":"2015","author":"Toptas","year":"2015","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/gut.36.5.792","article-title":"Fulminant hepatic failure caused by tuberculosis","volume":"36","author":"Hussain","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2023.01.008_bib14","doi-asserted-by":"crossref","first-page":"e12658","DOI":"10.1111\/tid.12658","article-title":"Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment","volume":"19","author":"Bartoletti","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejim.2004.04.004","article-title":"Obstructive jaundice and hematemesis: two cases with unusual presentations of intra-abdominal tuberculosis","volume":"15","author":"Jazet","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.2012.11-0643","article-title":"Case report: portal hypertension secondary to isolated liver tuberculosis","volume":"87","author":"Mojtahedzadeh","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mcna.2023.01.008_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3855\/jidc.12187","article-title":"A\u00a0case of tuberculosis presented by obstructive jaundice tuberculosis-related mechanical icterus","volume":"14","author":"Ocak Serin","year":"2020","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.mcna.2023.01.008_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2000.01944.x","article-title":"Biliary tuberculosis mimicking cholangiocarcinoma: treatment with metallic biliary endoprothesis","volume":"95","author":"Inal","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clinimag.2021.02.012","article-title":"TB or not TB: a comprehensive review of imaging manifestations of abdominal tuberculosis and its mimics","volume":"76","author":"Ladumor","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1016\/j.mcna.2023.01.008_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2143(96)90184-5","article-title":"Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas","volume":"127","author":"Diaz","year":"1996","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib21","first-page":"131","article-title":"Hepatic tuberculosis","volume":"41","author":"Puri","year":"1994","journal-title":"Indian J Tubercul"},{"issue":"8","key":"10.1016\/j.mcna.2023.01.008_bib22","article-title":"Xpert(\u00ae) MTB\/RIF assay for extrapulmonary tuberculosis and rifampicin resistance","author":"Kohli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2023.01.008_bib23","article-title":"Xpert MTB\/RIF Ultra and Xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults","author":"Kohli","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2023.01.008_bib24","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.mcna.2023.01.008_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/ijmr.IJMR_1950_16","article-title":"Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India","volume":"145","author":"Sharma","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.mcna.2023.01.008_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12879-020-05225-x","article-title":"Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China","volume":"20","author":"Xue","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1800762","article-title":"Prednisone for the prevention of paradoxical tuberculosis-associated IRIS","volume":"379","author":"Meintjes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib28","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.2147\/IJGM.S336850","article-title":"Analysis of clinical manifestations of acute and chronic brucellosis in patients admitted to a public general hospital in Northern China","volume":"14","author":"Liu","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib30","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/pathogens10121623","article-title":"Microbiological laboratory diagnosis of human brucellosis: an overview","volume":"10","author":"Di Bonaventura","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.mcna.2023.01.008_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/tmi.12856","article-title":"Human-to-human transmission of Brucella - a systematic review","volume":"22","author":"Tuon","year":"2017","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.mcna.2023.01.008_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cgh.2006.08.010","article-title":"The liver in brucellosis","volume":"5","author":"Akritidis","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10096-014-2064-4","article-title":"Liver involvement in patients with brucellosis: results of the Marmara study","volume":"33","author":"Ozturk-Engin","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3349\/ymj.2003.44.1.33","article-title":"Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey","volume":"44","author":"G\u00fcr","year":"2003","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.mcna.2023.01.008_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4269\/ajtmh.15-0225","article-title":"Patterns of hepatosplenic brucella abscesses on cross-sectional imaging: a review of clinical and imaging features","volume":"93","author":"Heller","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mcna.2023.01.008_bib36","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/319608","article-title":"Current understanding and management of chronic hepatosplenic suppurative brucellosis","volume":"32","author":"Ariza","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib37","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.humpath.2014.07.007","article-title":"Liver histology of acute brucellosis caused by Brucella melitensis","volume":"45","author":"Young","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.mcna.2023.01.008_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s15010-021-01586-w","article-title":"The current therapeutical strategies in human brucellosis","volume":"49","author":"Bosilkovski","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.mcna.2023.01.008_bib39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/pathogens10091125","article-title":"Current evidence on the antimicrobial treatment and chemoprophylaxis of human leptospirosis: a meta-analysis","volume":"10","author":"Guzm\u00e1n P\u00e9rez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.mcna.2023.01.008_bib40","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1590\/s1678-9946201860023","article-title":"Pathology and pathogenesis of human leptospirosis: a commented review","volume":"60","author":"De Brito","year":"2018","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.mcna.2023.01.008_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: a zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-0716-0459-5_25","article-title":"Laboratory diagnosis of leptospirosis","volume":"2134","author":"Koizumi","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.mcna.2023.01.008_bib43","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S1473-3099(22)00290-0","article-title":"Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study","volume":"22","author":"Manabe","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/14656566.5.4.819","article-title":"The management of leptospirosis","volume":"5","author":"Faucher","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mcna.2023.01.008_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198402233100805","article-title":"An efficacy trial of doxycycline chemoprophylaxis against leptospirosis","volume":"310","author":"Takafuji","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2023.01.008_bib46","article-title":"Antibiotic prophylaxis for leptospirosis","author":"Brett-Major","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2023.01.008_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.idc.2021.03.011","article-title":"Histoplasmosis","volume":"35","author":"Ara\u00faz","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.mcna.2023.01.008_bib48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.14218\/JCTH.2020.00080","article-title":"Hepatic histoplasmosis: an update","volume":"10","author":"Sayeed","year":"2022","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib49","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S1473-3099(21)00191-2","article-title":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology","volume":"21","author":"Thompson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib50","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/md.0b013e3180679130","article-title":"Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients","volume":"86","author":"Assi","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcna.2023.01.008_bib52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/000313480106700509","article-title":"Histoplasmosis as an isolated liver lesion: review and surgical therapy","volume":"67","author":"Martin","year":"2001","journal-title":"Am Surg"},{"key":"10.1016\/j.mcna.2023.01.008_bib53","doi-asserted-by":"crossref","first-page":"879535","DOI":"10.1155\/2014\/879535","article-title":"Histoplasmosis presenting as granulomatous hepatitis: case report and review of the literature","volume":"2014","author":"Rihana","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib54","doi-asserted-by":"crossref","first-page":"6901514","DOI":"10.1155\/2020\/6901514","article-title":"A\u00a0case of hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis","volume":"2020","author":"Columbus-Morales","year":"2020","journal-title":"Case Reports Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/X0Y2-P3GY-TWE8-DM02","article-title":"The pathologic spectrum of gastrointestinal and hepatic histoplasmosis","volume":"113","author":"Lamps","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.mcna.2023.01.008_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccm.2017.04.004","article-title":"Clinical perspectives in the diagnosis and management of histoplasmosis","volume":"38","author":"Azar","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib57","first-page":"129","article-title":"Diagnostic methods for histoplasmosis: focus on endemic countries with variable infrastructure levels","volume":"1","author":"Scheel","year":"2014","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.mcna.2023.01.008_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CVI.00389-10","article-title":"Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay","volume":"18","author":"Hage","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mcna.2023.01.008_bib59","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2023.01.008_bib60","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/liv.14984","article-title":"COVID-19 and the liver: a 2021 update","volume":"41","author":"Spearman","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.mcna.2023.01.008_bib61","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2023.01.008_bib63","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/liv.14583","article-title":"Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: a multicentre United States experience","volume":"40","author":"Hashemi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.mcna.2023.01.008_bib64","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCG.0000000000001481","article-title":"COVID-19 in chronic liver disease and liver transplantation: a clinical review","volume":"55","author":"Mohammed","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib66","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2023.01.008_bib67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib68","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives","volume":"18","author":"Marjot","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib69","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.mcna.2023.01.008_bib70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MEG.0000000000001808","article-title":"COVID-19 and the liver: overview","volume":"33","author":"Amin","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib71","doi-asserted-by":"crossref","first-page":"153451","DOI":"10.1016\/j.prp.2021.153451","article-title":"Liver histopathology in COVID-19 patients: a mono-institutional series of liver biopsies and autopsy specimens","volume":"221","author":"Fassan","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.mcna.2023.01.008_bib72","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3748\/wjg.v26.i48.7693","article-title":"High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: a systematic review and meta-analysis of autopsy data","volume":"26","author":"D\u00edaz","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib73","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.14309\/ajg.0000000000001264","article-title":"Cholangiopathy after severe COVID-19: clinical features and prognostic implications","volume":"116","author":"Faruqui","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib74","doi-asserted-by":"crossref","first-page":"200384","DOI":"10.1183\/16000617.0384-2020","article-title":"Current evidence for COVID-19 therapies: a systematic literature review","volume":"30","author":"Welte","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.mcna.2023.01.008_bib75","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. 2022, 2022. Available at: https:\/\/covid19.who.int\/. Accessed December 12, 2022."},{"key":"10.1016\/j.mcna.2023.01.008_bib76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib77","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib78","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib79","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2023.01.008_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0022-2015","article-title":"Cytomegalovirus","volume":"4","author":"Dioverti","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mcna.2023.01.008_bib81","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.mcna.2023.01.008_bib82","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10096-020-03814-x","article-title":"Thirty years of CMV seroprevalence-a longitudinal analysis in a German university hospital","volume":"39","author":"Hoehl","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.mcna.2023.01.008_bib83","doi-asserted-by":"crossref","first-page":"S701","DOI":"10.1093\/clinids\/12.Supplement_7.S701","article-title":"Epidemiology of cytomegalovirus infections","volume":"12","author":"Ho","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.mcna.2023.01.008_bib85","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/649903","article-title":"Cytomegalovirus reinfections in healthy seroimmune women","volume":"201","author":"Ross","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib87","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2012.10.017","article-title":"Re-evaluation of the VIDAS(\u00ae) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation","volume":"56","author":"Vauloup-Fellous","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.mcna.2023.01.008_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/341079","article-title":"Dynamics of CD4 and CD8 T\u00a0cell responses to cytomegalovirus in healthy human donors","volume":"186","author":"Dunn","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib89","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1586\/eci.12.25","article-title":"Immune response to CMV in solid organ transplant recipients: current concepts and future directions","volume":"8","author":"Watkins","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.mcna.2023.01.008_bib90","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/121.6.608","article-title":"Infectious-mononucleosis-like disease with negative heterophil agglutination test. clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies","volume":"121","author":"Klemola","year":"1970","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198503000-00003","article-title":"Cytomegalovirus infection in the normal host","volume":"64","author":"Cohen","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcna.2023.01.008_bib92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/acb.2001.051","article-title":"Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature","volume":"56","author":"Tjwa","year":"2001","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.mcna.2023.01.008_bib93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00595-012-0209-6","article-title":"Cytomegalovirus infection-associated fulminant hepatitis in an immunocompetent adult requiring emergency living-donor liver transplantation: report of a case","volume":"43","author":"Yu","year":"2013","journal-title":"Surg Today"},{"key":"10.1016\/j.mcna.2023.01.008_bib94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2021.09.011","article-title":"Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease","volume":"76","author":"De Broucker","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 4","key":"10.1016\/j.mcna.2023.01.008_bib95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mcna.2023.01.008_bib96","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.mcna.2023.01.008_bib97","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib98","first-page":"13","article-title":"CMV infection in bone marrow and solid organ transplant patients in the era of antiviral prophylaxis","volume":"7","author":"Hebart","year":"2000","journal-title":"Herpes"},{"key":"10.1016\/j.mcna.2023.01.008_bib99","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1600-6143.2005.00797.x","article-title":"Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+\/R- transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mcna.2023.01.008_bib100","first-page":"106","article-title":"Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts","volume":"9","author":"Da Cunha","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cid\/ciaa1713","article-title":"Letermovir and Maribavir for the treatment and prevention of cytomegalovirus infection in solid organ and stem cell transplant recipients","volume":"73","author":"Imlay","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib102","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40265-022-01677-4","article-title":"Maribavir: first approval","volume":"82","author":"Kang","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2023.01.008_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.mcna.2023.01.008_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib105","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.mcna.2023.01.008_bib106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12875-019-0954-3","article-title":"Epstein-Barr virus and its association with disease - a review of relevance to general practice","volume":"20","author":"Fugl","year":"2019","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.mcna.2023.01.008_bib107","first-page":"446","article-title":"Hepatitis caused by herpes viruses: a review","volume":"19","author":"Noor","year":"2018","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib108","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.hepres.2005.06.005","article-title":"Epstein-Barr virus induced hepatitis: an important cause of cholestasis","volume":"33","author":"Shaukat","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.mcna.2023.01.008_bib109","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s10620-014-3029-2","article-title":"Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group","volume":"59","author":"Mellinger","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2023.01.008_bib110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gtc.2020.01.008","article-title":"Epstein-Barr Virus and cytomegalovirus infections of the liver","volume":"49","author":"Bunchorntavakul","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.mcna.2023.01.008_bib111","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004836-198906000-00021","article-title":"Chronic Epstein-Barr virus infection: a cause of granulomatous hepatitis?","volume":"11","author":"Biest","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1023\/A:1005434015863","article-title":"Vanishing bile duct syndrome associated with chronic EBV infection","volume":"45","author":"Kikuchi","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2023.01.008_bib113","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12664-015-0613-0","article-title":"Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults","volume":"34","author":"Gupta","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib114","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mcna.2023.01.008_bib115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.mcna.2023.01.008_bib116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2018.12.010","article-title":"Hepatic manifestations of lymphoproliferative disorders","volume":"23","author":"Bunchorntavakul","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib117","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mcna.2023.01.008_bib118","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.mcna.2023.01.008_bib119","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-Barr Virus Hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib120","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1440-1746.2006.03257.x","article-title":"Ganciclovir and the treatment of Epstein-Barr virus hepatitis","volume":"21","author":"Adams","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2018.12.012","article-title":"Sarcoidosis and the liver","volume":"23","author":"Kumar","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.mcna.2023.01.008_bib122","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib123","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib124","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0040-1713799","article-title":"Hepatic sarcoidosis: current concepts and treatments","volume":"41","author":"Rossi","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MCG.0b013e318247106b","article-title":"Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis","volume":"46","author":"Dulai","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib126","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-61-3-455","article-title":"The fever of sarcoidosis","volume":"61","author":"Nolan","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib127","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ajg.2017.231","article-title":"Clinical characteristics and outcome of hepatic sarcoidosis: a population-based study 1976-2013","volume":"112","author":"Ungprasert","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib128","first-page":"531","article-title":"Hepatic sarcoidosis with portal hypertension. a report of seven cases with a review of the literature","volume":"63","author":"Valla","year":"1987","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib129","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.510260304","article-title":"The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis","volume":"26","author":"Moreno-Merlo","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2023.01.008_bib130","first-page":"71","article-title":"Budd-Chiari syndrome in sarcoidosis","volume":"81","author":"Russi","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib131","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4081\/cp.2015.768","article-title":"Budd-Chiari syndrome: an unusual presentation of multisystemic sarcoidosis","volume":"5","author":"Ennaifer","year":"2015","journal-title":"Clin Pract"},{"key":"10.1016\/j.mcna.2023.01.008_bib132","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/00365521.2016.1177856","article-title":"Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options","volume":"51","author":"Syed","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib133","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cld.1002","article-title":"Hepatic sarcoidosis: incidence, monitoring, and treatment","volume":"16","author":"Ryland","year":"2020","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.mcna.2023.01.008_bib134","series-title":"Hepatology: a textbook of liver diseases","first-page":"1472","author":"Zakim","year":"1996"},{"key":"10.1016\/j.mcna.2023.01.008_bib135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MEG.0b013e32834c7b71","article-title":"Liver-test abnormalities in sarcoidosis","volume":"24","author":"Cremers","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib136","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/17474124.2015.958468","article-title":"Clinical presentation and protocol for management of hepatic sarcoidosis","volume":"9","author":"Modaresi Esfeh","year":"2015","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib137","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiology.192.1.8208972","article-title":"Abdominal CT findings in sarcoidosis: radiologic and clinical correlation","volume":"192","author":"Warshauer","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.mcna.2023.01.008_bib138","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00330-015-4169-2","article-title":"Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution","volume":"26","author":"Fetzer","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mcna.2023.01.008_bib139","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00005792-197009000-00002","article-title":"Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients","volume":"49","author":"Maddrey","year":"1970","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcna.2023.01.008_bib140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.meg.0000223911.85739.38","article-title":"Natural history of hepatic sarcoidosis and its response to treatment","volume":"18","author":"Kennedy","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib141","first-page":"349","article-title":"Sarcoidosis of the liver: to treat or not to treat?","volume":"70","author":"Bakker","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib142","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11938-006-0004-9","article-title":"Diagnosis and treatment of hepatic sarcoidosis","volume":"9","author":"Ayyala","year":"2006","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.mcna.2023.01.008_bib143","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.28966","article-title":"Anti-TNF-\u03b1 for necrotizing sarcoid granulomatosis of the liver","volume":"65","author":"Sebode","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2023.01.008_bib144","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jceh.2016.02.005","article-title":"Long-term outcomes of liver transplantation for hepatic sarcoidosis: a single center experience","volume":"6","author":"Bilal","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000695","article-title":"Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management","volume":"28","author":"Syed","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2023.01.008_bib146","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib147","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.mcna.2023.01.008_bib148","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.mcna.2023.01.008_bib149","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.32.2.227","article-title":"Sinusoidal portal hypertension in hepatic amyloidosis","volume":"32","author":"Bion","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2023.01.008_bib150","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2016-08-730978","article-title":"The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity","volume":"129","author":"Oliva","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.mcna.2023.01.008_bib151","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib152","first-page":"S107","article-title":"Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges","volume":"23","author":"Gertz","year":"2017","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.mcna.2023.01.008_bib153","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1177\/00031348211023427","article-title":"Combined heart-liver and domino liver transplantation in familial amyloidosis","volume":"88","author":"Sickels","year":"2022","journal-title":"Am Surg"},{"key":"10.1016\/j.mcna.2023.01.008_bib154","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"Carvalho","year":"2015","journal-title":"Liver Transplant"},{"key":"10.1016\/j.mcna.2023.01.008_bib155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1432-2277.2008.00737.x","article-title":"High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy","volume":"22","author":"Bispo","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.mcna.2023.01.008_bib156","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/lt.22174","article-title":"Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation","volume":"16","author":"Llad\u00f3","year":"2010","journal-title":"Liver Transplant"},{"key":"10.1016\/j.mcna.2023.01.008_bib157","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2023.01.008_bib158","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib159","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2023.01.008_bib160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.prp.2012.07.011","article-title":"Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis","volume":"208","author":"Sarsik","year":"2012","journal-title":"Pathol Res Pract"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:48:48Z","timestamp":1758419328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712523000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0025712523000196"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2023.01.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Manifestations of Systemic Diseases","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}